- Home
- STRM vs MIRA Comparison
STRM vs MIRA Comparison
Compare STRM & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRM
- MIRA
- Stock Information
- Founded
- STRM 1989
- MIRA 2020
- Country
- STRM United States
- MIRA United States
- Employees
- STRM N/A
- MIRA N/A
- Industry
- STRM EDP Services
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- STRM Technology
- MIRA Health Care
- Exchange
- STRM Nasdaq
- MIRA Nasdaq
- Market Cap
- STRM 15.4M
- MIRA 16.6M
- IPO Year
- STRM 1996
- MIRA 2023
- Fundamental
- Price
- STRM $3.14
- MIRA $1.25
- Analyst Decision
- STRM
- MIRA Strong Buy
- Analyst Count
- STRM 0
- MIRA 2
- Target Price
- STRM N/A
- MIRA $14.00
- AVG Volume (30 Days)
- STRM 11.7K
- MIRA 261.0K
- Earning Date
- STRM 04-28-2025
- MIRA 03-31-2025
- Dividend Yield
- STRM N/A
- MIRA N/A
- EPS Growth
- STRM N/A
- MIRA N/A
- EPS
- STRM N/A
- MIRA N/A
- Revenue
- STRM $18,587,000.00
- MIRA N/A
- Revenue This Year
- STRM N/A
- MIRA N/A
- Revenue Next Year
- STRM $4.04
- MIRA N/A
- P/E Ratio
- STRM N/A
- MIRA N/A
- Revenue Growth
- STRM N/A
- MIRA N/A
- 52 Week Low
- STRM $1.85
- MIRA $0.51
- 52 Week High
- STRM $9.75
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- STRM 37.14
- MIRA 64.63
- Support Level
- STRM $3.05
- MIRA $0.90
- Resistance Level
- STRM $3.27
- MIRA $1.08
- Average True Range (ATR)
- STRM 0.18
- MIRA 0.11
- MACD
- STRM -0.03
- MIRA 0.02
- Stochastic Oscillator
- STRM 12.68
- MIRA 85.23
About STRM Streamline Health Solutions Inc.
Streamline Health Solutions Inc provides transformational data-driven solutions for healthcare organizations. It provides computer software-based solutions through its looking glass platform. Its solutions include coding and CDI, coding audit, and financial management solutions. It offers various services, such as custom integration services, training services, electronic image conversion and database monitoring services. It sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.